---
figid: PMC2981059__carcinbgq188f06_4c
figlink: /pmc/articles/PMC2981059/figure/fig6/
number: Fig. 6
caption: The HER/HER2-PI3K-Akt-NF-κB-elicited pathway in prostate cancer cells. PI3K-Akt
  signaling cross talks with the NF-κB-mediated pathway by Akt phosphorylation and
  activation of IKK, an upstream kinase of NF-κB. Small molecule inhibitors Erlotinib,
  Gefitinib, Lapatinib, CI-1033, LY294002, Bortezomib, cFLSYR and c(2NapA)LS(2NapA)R
  against EGFR, HER2, PI3K, NF-κB and sPLA2 are indicated.
pmcid: PMC2981059
papertitle: Secretory phospholipase A2-IIa is involved in prostate cancer progression
  and may potentially serve as a biomarker for prostate cancer.
reftext: Zhongyun Dong, et al. Carcinogenesis. 2010 Nov;31(11):1948-1955.
pmc_ranked_result_index: '7436'
pathway_score: 0.9422654
filename: carcinbgq188f06_4c.jpg
figtitle: HER/HER2-PI3K-Akt-NFKB-elicited pathway in prostate cancer cells
year: '2010'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2981059__carcinbgq188f06_4c.html
  '@type': Dataset
  description: The HER/HER2-PI3K-Akt-NF-κB-elicited pathway in prostate cancer cells.
    PI3K-Akt signaling cross talks with the NF-κB-mediated pathway by Akt phosphorylation
    and activation of IKK, an upstream kinase of NF-κB. Small molecule inhibitors
    Erlotinib, Gefitinib, Lapatinib, CI-1033, LY294002, Bortezomib, cFLSYR and c(2NapA)LS(2NapA)R
    against EGFR, HER2, PI3K, NF-κB and sPLA2 are indicated.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R3
  - AKT2
  - PTEN
  - PIK3CG
  - AKT1
  - PIK3R4
  - PIK3CD
  - IKBKB
  - AKT3
  - RELA
  - PIK3CA
  - PIK3CB
  - ERBB2
  - PIK3R5
  - IKBKG
  - EGF
  - AR
  - PIK3R6
  - CHUK
  - LY294002
  - PGE2
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RelA
  symbol: RELA
  source: hgnc_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: HER/HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
chemicals:
- word: LY294002
  source: MESH
  identifier: C085911
- word: PGE2
  source: MESH
  identifier: D015232
diseases: []
---
